Binnopharm Group localizes production of Chinese asthma drug in Russia

Pharmaceutical company Binnopharm Group (part of AFK Sistema) and the Chinese biopharmaceutical company Mabwell have signed an agreement on the localization in Russia and the EAEU countries of a drug for the treatment of atopic dermatitis and bronchial asthma.